Clorox (NYSE:CLX) Given New $155.00 Price Target at Evercore ISI

Clorox (NYSE:CLX) had its price objective lifted by investment analysts at Evercore ISI from $145.00 to $155.00 in a research note issued to investors on Tuesday. Evercore ISI’s price objective would suggest a potential upside of 2.41% from the company’s previous close.

Several other equities research analysts also recently issued reports on the stock. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, Wells Fargo & Company lifted their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox has an average rating of “Hold” and an average target price of $157.64.

Clorox Stock Performance

NYSE:CLX traded down $8.42 during mid-day trading on Tuesday, hitting $151.36. The stock had a trading volume of 1,377,391 shares, compared to its average volume of 1,142,576. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37. The stock has a market cap of $18.74 billion, a price-to-earnings ratio of 52.68, a PEG ratio of 2.92 and a beta of 0.42. The company’s 50 day simple moving average is $162.76 and its 200 day simple moving average is $158.50. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period in the prior year, the company posted $2.16 earnings per share. On average, equities research analysts forecast that Clorox will post 6.86 earnings per share for the current year.

Institutional Trading of Clorox

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new stake in shares of Clorox in the third quarter worth $27,000. Continuum Advisory LLC grew its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Asset Planning Inc bought a new stake in shares of Clorox in the fourth quarter worth $32,000. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Clorox in the third quarter worth $48,000. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.